Delivery Order SPE2DB25D3201-SPE2DB25FNSEC

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,529.24 firm fixed-price contract is for the supply of cefazolin 2 g/50 ml dextrose, a critical intravenous antibiotic medication. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,445.28 firm fixed price contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication, with a performance period through November 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefazolin 2 g/50 mL-Dextroses, a type of antibiotic medication, with a ceiling value of $2,707.14 and a period of performance through May 22, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a prescription antibiotic medication, with a ceiling value of $1,228.56 and a performance period ending on May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.46, is for the delivery of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The contract has a firm fixed price pricing type and a completion date of November 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,924,778 units of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The order has a ceiling value of $1,445.28 and is a firm fixed-price contract. The ultimate completion date for this delivery order is September 25, 2024. This award is not a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.28 firm fixed-price contract is for the supply of Cefazolin 2 g/50 ml-dextrose, a generic antibiotic medication, to support military healthcare programs. The delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.08, is for the supply of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract is a Firm Fixed Price agreement with a period of performance through January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 g/50 ml-dextrose, a critical care medication. The award has a ceiling value of $1,583.28 and an ultimate completion date of July 23, 2024. The contract is a firm-fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,073.02, is for the supply of cefazolin 2g/50ml-dextrose, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNSEC
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,529.24, is for the supply of Cefazolin 2 g/50 ml-Dextroses, a type of antibiotic medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/3/25, 2:54 PM